Examples of Novartis License Agreement in a sentence
The Novartis License Agreement contains indemnification obligations of EPI that include claims relating to infringement of Purchased Intellectual Property.
Novartis License Agreement On March 23, 2017, the Company entered into an exclusive license agreement with Novartis International Pharmaceutical Ltd.
However, the terms of the Novartis License Agreement shall prevail over any conflicting terms contained in this Territory License Agreement.
Seller has no intention of terminating the Novartis License Agreement.
Under the terms of the Novartis License Agreement, the Company has granted Novartis an exclusive right and license, with the right to grant certain sublicenses, under the Company’s intellectual property reasonably necessary or useful for the development or commercialization of LUXTURNA for the treatment, prevention, cure or control of RPE65- mediated inherited retinal disease (IRD) in humans outside the United States.
This Amendment No. 6 shall be deemed incorporated into and become a part of the Novartis License Agreement and shall be subject to its terms.
Notwithstanding anything to the contrary herein, Purchaser shall not assign any of its rights or obligations under the Novartis License Agreement without the prior written consent of Sellers, such consent not to be unreasonably withheld, except that Purchaser may assign its rights or obligations in the event that Novartis has provided QLTI a written release of all of QLTI’s obligations thereunder.
To the Knowledge of Seller, no event has occurred that, with notice or the passage of time or both, would (1) give Novartis the right to cease paying Novartis Royalty Payments, (2) give Novartis or Seller the right to terminate the Novartis License Agreement, or (3) constitute or give rise to any breach or default in the performance of the Novartis License Agreement by Seller or Novartis.
There are no waivers, or modifications (or pending requests therefor) in respect of the Novartis License Agreement.
Novartis has not exercised, and, to the Knowledge of Seller, has not had the right to exercise, and no event or condition exists that, upon notice or passage of time or both, could reasonably be expected to permit Novartis to exercise, any Set-off against the Novartis Royalty Payments or any other amounts payable to Seller under the Novartis License Agreement.